Daxor Announces NorthCrest Medical Center of Springfield, TN Acquires Blood Volume Analyzer BVA-100
Posted on: Thursday, 6 September 2007, 09:11 CDT
Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement for a Blood Volume Analyzer BVA-100 from NorthCrest Medical Center of Springfield, Tennessee.
NorthCrest Medical Center is a fully accredited, 109-bed facility servicing Robertson and surrounding Tennessee counties as well as southern Kentucky. Supported by state-of-the-art equipment, including an in-house cardiovascular lab, a full range of outpatient services and 24-hour emergency services, NorthCrest Medical Center's mission is to be the best 150-bed-or-less hospital in the country. NorthCrest Medical Center features more than 150 active and consulting physicians on the medical center staff providing a variety of services, which include cardiology, diagnostic and interventional radiology, emergency medicine, family practice, internal medicine, nephrology, neurology, obstetrics/gynecology ophthalmology, orthopedics, otolaryngology (ear, nose and throat), pediatrics, plastic and reconstructive surgery, pulmonology, general and vascular surgery, and urology.
NorthCrest Medical Center's interest in utilizing Daxor's Blood Volume Analyzer BVA-100 is to provide precise diagnostic information to physicians treating medical conditions in which intravascular blood volume abnormalities are frequently present but difficult to diagnose without the benefit of the BVA-100. Specifically, the BVA-100 will be used to diagnose intravascular blood volume derangements in heart failure, critical care and hematological conditions.
Other nationally renowned hospitals which have purchased the BVA-100 Blood Volume Analyzer after using it on a clinical trial agreement basis are The Mayo Clinic, The Cleveland Clinic, and New York University Medical Center. Daxor Corporation manufactures and markets the BVA-100, a semi-automated Blood Volume Analyzer. The BVA-100 is used in conjunction with Volumex, Daxor's single use diagnostic kit. For more information regarding Daxor Corporation's Blood Volume Analyzer BVA-100, visit Daxor's website www.Daxor.com.
Contact Information: Stephen Feldschuh Chief Operating Officer 212-330-8515 Email Contact or Diane Meegan Investor Relations 212-330-8512 Email Contact
SOURCE: Daxor Corp.
Source: MARKET WIRE
Related Articles
- Daxor Announces a Union Hospital Purchase and a Separate Trial of Blood Volume Analyzer BVA-100
- Daxor Announces Westchester Medical Center of Valhalla, NY Purchases Blood Volume Analyzer BVA-100
- Daxor Announces St. Francis Hospital of Wilmington, DE Purchases Blood Volume Analyzer BVA-100
- Daxor Corporation Announces Queen's Medical Center of Honolulu, HI Purchases Second Blood Volume Analyzer
- Daxor Announces Virginia Commonwealth University Medical Center of Richmond, VA Acquires Blood Volume Analyzer BVA-100
- Daxor Announces Valley Hospital of Ridgewood, NJ Purchases Blood Volume Analyzer BVA-100
- Daxor Announces Saint Luke's Hospital of Bethlehem, PA Acquires Second Blood Volume Analyzer BVA-100
- Highly Efficient Blood Collection Device Makes U.S. Debut at Stanford Blood Center
- Natl. Sickle Cell Awareness Month: New York Blood Center, Kings County Hospital Center, Civic Leaders Call on Brooklyn Community to Donate Blood
User Comments (0)

RSS Feeds